Specific Inhibition of a Human Papillomavirus E2 Trans-Activator by Intracellular Delivery of Its Repressor

R. Blake Pepinsky, Karen Corina, Rhonda Brown, James Barsoum, Elliot J. Androphy

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Papillomaviruses are the causative agents of benign and malignant epithelial tumors of the skin and mucosa. They encode a DNA-binding protein, E2, that regulates viral transcription and replication, making it an important therapeutic target. By deleting the amino-terminal irans-activation domain of human papillomavirus type 16 (HPV-16) E2 while retaining its carboxy-terminal DNA binding and dimerization domain, an E2 repressor (E2R) that efficiently inhibits transcriptional activation by full-length HPV E2 was generated. To deliver this repressor protein into animal cells, we have utilized the human immunodeficiency virus type 1 (HIV-1) Tat protein which itself is taken up efficiently into intact cells. Chimeras of E2R and the cellular uptake domain of Tat specifically inhibited E2-dependent reporter gene expression in COS-7 cells. Treatment of cervical intraepithelial neoplasia cells having episomally replicating HPV-31 DNA with this Tat-E2R protein led to a dose-dependent loss of HPV DNA copies and inhibition of cell growth. Tat-mediated delivery can be a valuable tool for assessing protein function and may allow the development of novel therapeutic proteins having intracellular targets.

Original languageEnglish (US)
Pages (from-to)1011-1019
Number of pages9
JournalDNA and Cell Biology
Volume13
Issue number10
DOIs
StatePublished - Oct 1994

Fingerprint

Trans-Activators
Repressor Proteins
DNA
Human papillomavirus 31
tat Gene Products
Cervical Intraepithelial Neoplasia
Human papillomavirus 16
COS Cells
DNA-Binding Proteins
Dimerization
Reporter Genes
Transcriptional Activation
HIV-1
Mucous Membrane
Proteins
Carcinoma
Gene Expression
Skin
Therapeutics
Growth

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Specific Inhibition of a Human Papillomavirus E2 Trans-Activator by Intracellular Delivery of Its Repressor. / Pepinsky, R. Blake; Corina, Karen; Brown, Rhonda; Barsoum, James; Androphy, Elliot J.

In: DNA and Cell Biology, Vol. 13, No. 10, 10.1994, p. 1011-1019.

Research output: Contribution to journalArticle

Pepinsky, R. Blake ; Corina, Karen ; Brown, Rhonda ; Barsoum, James ; Androphy, Elliot J. / Specific Inhibition of a Human Papillomavirus E2 Trans-Activator by Intracellular Delivery of Its Repressor. In: DNA and Cell Biology. 1994 ; Vol. 13, No. 10. pp. 1011-1019.
@article{aad4e68403f3462b96515f08e648a0cc,
title = "Specific Inhibition of a Human Papillomavirus E2 Trans-Activator by Intracellular Delivery of Its Repressor",
abstract = "Papillomaviruses are the causative agents of benign and malignant epithelial tumors of the skin and mucosa. They encode a DNA-binding protein, E2, that regulates viral transcription and replication, making it an important therapeutic target. By deleting the amino-terminal irans-activation domain of human papillomavirus type 16 (HPV-16) E2 while retaining its carboxy-terminal DNA binding and dimerization domain, an E2 repressor (E2R) that efficiently inhibits transcriptional activation by full-length HPV E2 was generated. To deliver this repressor protein into animal cells, we have utilized the human immunodeficiency virus type 1 (HIV-1) Tat protein which itself is taken up efficiently into intact cells. Chimeras of E2R and the cellular uptake domain of Tat specifically inhibited E2-dependent reporter gene expression in COS-7 cells. Treatment of cervical intraepithelial neoplasia cells having episomally replicating HPV-31 DNA with this Tat-E2R protein led to a dose-dependent loss of HPV DNA copies and inhibition of cell growth. Tat-mediated delivery can be a valuable tool for assessing protein function and may allow the development of novel therapeutic proteins having intracellular targets.",
author = "Pepinsky, {R. Blake} and Karen Corina and Rhonda Brown and James Barsoum and Androphy, {Elliot J.}",
year = "1994",
month = "10",
doi = "10.1089/dna.1994.13.1011",
language = "English (US)",
volume = "13",
pages = "1011--1019",
journal = "DNA and Cell Biology",
issn = "1044-5498",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Specific Inhibition of a Human Papillomavirus E2 Trans-Activator by Intracellular Delivery of Its Repressor

AU - Pepinsky, R. Blake

AU - Corina, Karen

AU - Brown, Rhonda

AU - Barsoum, James

AU - Androphy, Elliot J.

PY - 1994/10

Y1 - 1994/10

N2 - Papillomaviruses are the causative agents of benign and malignant epithelial tumors of the skin and mucosa. They encode a DNA-binding protein, E2, that regulates viral transcription and replication, making it an important therapeutic target. By deleting the amino-terminal irans-activation domain of human papillomavirus type 16 (HPV-16) E2 while retaining its carboxy-terminal DNA binding and dimerization domain, an E2 repressor (E2R) that efficiently inhibits transcriptional activation by full-length HPV E2 was generated. To deliver this repressor protein into animal cells, we have utilized the human immunodeficiency virus type 1 (HIV-1) Tat protein which itself is taken up efficiently into intact cells. Chimeras of E2R and the cellular uptake domain of Tat specifically inhibited E2-dependent reporter gene expression in COS-7 cells. Treatment of cervical intraepithelial neoplasia cells having episomally replicating HPV-31 DNA with this Tat-E2R protein led to a dose-dependent loss of HPV DNA copies and inhibition of cell growth. Tat-mediated delivery can be a valuable tool for assessing protein function and may allow the development of novel therapeutic proteins having intracellular targets.

AB - Papillomaviruses are the causative agents of benign and malignant epithelial tumors of the skin and mucosa. They encode a DNA-binding protein, E2, that regulates viral transcription and replication, making it an important therapeutic target. By deleting the amino-terminal irans-activation domain of human papillomavirus type 16 (HPV-16) E2 while retaining its carboxy-terminal DNA binding and dimerization domain, an E2 repressor (E2R) that efficiently inhibits transcriptional activation by full-length HPV E2 was generated. To deliver this repressor protein into animal cells, we have utilized the human immunodeficiency virus type 1 (HIV-1) Tat protein which itself is taken up efficiently into intact cells. Chimeras of E2R and the cellular uptake domain of Tat specifically inhibited E2-dependent reporter gene expression in COS-7 cells. Treatment of cervical intraepithelial neoplasia cells having episomally replicating HPV-31 DNA with this Tat-E2R protein led to a dose-dependent loss of HPV DNA copies and inhibition of cell growth. Tat-mediated delivery can be a valuable tool for assessing protein function and may allow the development of novel therapeutic proteins having intracellular targets.

UR - http://www.scopus.com/inward/record.url?scp=0027971355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027971355&partnerID=8YFLogxK

U2 - 10.1089/dna.1994.13.1011

DO - 10.1089/dna.1994.13.1011

M3 - Article

C2 - 7945933

AN - SCOPUS:0027971355

VL - 13

SP - 1011

EP - 1019

JO - DNA and Cell Biology

JF - DNA and Cell Biology

SN - 1044-5498

IS - 10

ER -